marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-16-2024
Ultragenyx Pharmaceutical Financial Ratios 2011-2024 | RARE
Annual Financial Ratios Ultragenyx Pharmaceutical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.8 | -3.5 | -12.6 | -45.1 | -6.0 | -11.0 | -6.5 | -10.9 | -14.2 | -27.9 | - | - | - |
P/S |
8.1 | 6.7 | 16.2 | 31.1 | 23.3 | 42.0 | 753.8 | 20180.4 | - | - | - | - | - |
EPS |
-8.2 | -10.1 | -6.7 | -3.1 | -7.1 | -1.7 | -7.1 | -6.2 | -4.0 | -2.2 | -14.9 | -14.2 | - |
EV (Enterprise Value) |
4.53 B | 3.51 B | 5.99 B | 8.31 B | 2.46 B | 2.16 B | 1.98 B | 2.59 B | 2 B | 1.66 B | 2.11 M | -82.2 M | 1.49 M |
EBITDA per Share |
-7.39 | -9.02 | -5.44 | -5.22 | -7.35 | -7.07 | -7.61 | -6.18 | -3.98 | -1.95 | - | - | - |
EV/EBITDA |
-16.2 | -24.3 | -6.2 | -6.6 | -6.9 | -10.3 | -13.5 | -29.4 | - | - | - | ||
PEG |
-1.08 | -0.46 | 13.28 | -4.87 | -0.17 | -0.28 | 0.53 | 0.19 | 0.19 | -0.33 | - | - | - |
P/B |
12.8 | 7.0 | 6.2 | 7.3 | 3.7 | 3.6 | 5.1 | 5.7 | 3.9 | 9.0 | - | - | - |
P/CF |
-7.4 | -6.4 | -16.8 | -63.7 | -7.0 | -7.4 | -7.8 | -15.7 | -18.6 | -35.7 | - | - | - |
ROE % |
-220.26 | -200.69 | -49.21 | -16.16 | -61.60 | -32.45 | -78.79 | -51.87 | -27.42 | -32.34 | - | - | - |
ROA % |
-40.69 | -45.77 | -29.82 | -10.60 | -35.47 | -27.46 | -61.57 | -45.48 | -26.02 | -30.21 | - | - | - |
ROCE % |
-206.67 | -184.09 | -41.38 | -21.03 | -41.09 | -57.59 | -78.37 | -51.63 | -27.79 | -30.62 | - | - | - |
Current Ratio |
1.2 | 1.3 | 2.5 | 2.9 | 2.4 | 6.5 | 4.6 | 6.7 | 16.1 | 15.5 | - | - | - |
DSO |
47.8 | 34.6 | 26.8 | 37.7 | 80.2 | 63.5 | 361.4 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | 1245.7 | 138152.5 | - | - | - | - | - | - |
DPO |
- | - | - | - | - | 3369.9 | 2600625.0 | - | - | - | - | - | - |
Operating Cycle |
47.8 | 34.6 | 26.8 | 37.7 | 80.2 | 1309.1 | 138513.9 | - | - | - | - | - | - |
Cash Conversion Cycle |
47.8 | 34.6 | 26.8 | 37.7 | 80.2 | -2060.8 | -2462111.1 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Ultragenyx Pharmaceutical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.4 | -1.52 | -2.03 | - | -2.23 | -2.25 | -2.33 | - | -3.5 | -2.26 | -2.19 | - | -1.08 | -1.81 | -2.03 | -0.37 | -1.13 | 0.42 | -2.05 | -1.62 | -1.96 | -1.72 | -1.82 | -1.73 | -1.74 | -1.06 | 0.63 | -1.89 | -1.87 | -1.72 | -1.63 | -1.75 | -1.64 | -1.46 | -1.35 | -1.42 | -1.03 | -0.83 | -0.63 | -0.52 | -0.5 | -0.45 | -0.85 | -4.98 | -3.48 | -3.32 | -2.84 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.86 | - | - | - | -2.12 | - | -3.21 | -2.02 | -1.91 | - | -1.32 | -1.22 | -1.54 | - | -0.68 | -0.95 | -1.98 | - | -1.93 | -1.88 | -1.82 | - | -1.45 | -1.66 | -1.87 | - | -1.89 | -1.8 | -1.64 | - | -1.61 | -1.46 | -1.36 | - | -1.02 | -0.83 | -0.63 | - | -0.49 | -0.45 | -0.47 | - | -2.05 | -2.29 | -1.91 | - | - | - | - | - | - | - | - |
ROE % |
-694.02 | -1158.93 | -1252.36 | -701.64 | -753.92 | -302.80 | -202.26 | -94.73 | -102.55 | -58.09 | -47.36 | -33.32 | -35.40 | -37.92 | -21.68 | -28.31 | -40.58 | -45.79 | -61.52 | -52.89 | -52.97 | -51.77 | -48.33 | -32.45 | -39.34 | -45.67 | -56.02 | -78.79 | -72.52 | -65.55 | -58.55 | -51.87 | -47.23 | -40.93 | -34.52 | -27.42 | -26.07 | -27.25 | -28.99 | -32.34 | -8.16 | 11.67 | 30.50 | 46.87 | 31.75 | 20.48 | 9.00 | - | - | - | - | - | - | - | - |
ROA % |
-42.76 | -46.98 | -51.04 | -36.94 | -52.08 | -54.33 | -54.12 | -38.13 | -43.04 | -32.81 | -28.93 | -21.53 | -22.90 | -23.41 | -13.39 | -14.52 | -21.41 | -25.94 | -36.60 | -35.47 | -39.41 | -41.59 | -40.19 | -27.46 | -31.91 | -35.92 | -43.45 | -61.57 | -58.10 | -53.96 | -49.64 | -45.48 | -42.16 | -37.17 | -31.96 | -26.02 | -24.61 | -25.60 | -27.14 | -30.21 | -40.73 | -46.85 | -54.39 | -58.79 | -39.82 | -25.69 | -11.29 | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | -48.01 | -96.01 | -116.89 | -86.04 | -95.66 | -57.28 | -44.91 | -28.24 | -35.79 | -33.73 | -34.28 | -36.43 | -52.66 | -61.33 | -65.99 | -41.14 | -55.86 | -54.35 | -56.22 | -46.15 | -67.98 | -75.09 | -79.96 | -60.53 | -74.41 | -66.46 | -58.25 | -37.44 | -44.96 | -38.60 | -32.03 | -17.24 | -25.81 | -26.85 | -28.56 | -21.54 | -11.17 | 7.77 | 26.18 | 30.41 | 30.41 | 20.04 | 9.02 | - | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 1.4 | 1.1 | 1.2 | 1.0 | 1.1 | 1.2 | 1.3 | 1.4 | 2.1 | 2.4 | 2.5 | 2.7 | 2.8 | 2.9 | 2.9 | 2.1 | 2.1 | 2.0 | 2.4 | 2.4 | 2.4 | 2.4 | 6.5 | 6.5 | 6.5 | 6.5 | 4.6 | 4.6 | 4.6 | 4.6 | 8.1 | 8.1 | 8.1 | 8.1 | 19.6 | 19.6 | 19.6 | 19.6 | 15.2 | 15.2 | 15.2 | 15.2 | 6.2 | 6.2 | 6.2 | 6.2 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | 32.4 | - | 28.0 | 26.1 | 22.1 | 23.0 | 25.9 | 34.1 | 70.3 | 84.2 | 116.2 | 124.1 | 114.5 | 71.5 | 98.8 | 90.9 | 76.5 | 195.5 | 2383.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1375.4 | 1878.6 | - | 2361.5 | 4572.2 | 1586.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1533.3 | 2538.2 | - | 4102.9 | 7943.9 | 4291.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | 32.4 | - | 28.0 | 26.1 | 22.1 | 23.0 | 25.9 | 34.1 | 70.3 | 84.2 | 116.2 | 1499.5 | 1993.0 | 71.5 | 2460.3 | 4663.1 | 1662.7 | 195.5 | 2383.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | 32.4 | - | 28.0 | 26.1 | 22.1 | 23.0 | 25.9 | 34.1 | 70.3 | 84.2 | 116.2 | -33.7 | -545.2 | 71.5 | -1642.6 | -3280.9 | -2628.3 | 195.5 | 2383.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency